This site uses cookies to improve your browsing experience. By using this site, you agree to their use. Cookie Information

ESMO, Barcelona, Spain 26-30 September 2019

A combined analysis of two Phase IIIb studies of afatinib in EGFR TKI-naïve patients with EGFR mutation-positive NSCLC

Filippo De Marinis, Haiyan Tu, Konstantin K Laktionov, Jifeng Feng, Artem Poltoratskiy, Jun Zhao, Inna Egorova, Eng-Huat Tan, Maya Gottfried, Victor Lee, Dariusz Kowalski, Cheng-Ta Yang, BJ Srinivasa, Antonio Passaro, Laura Clementi, Wenbo Tang, Dennis Chin-Lun Huang, Agnieszka Cseh, Caicun Zhou, Yi-Long Wu

1200.55.66

Related Materials

Learn more about the science behind this poster in the videos, papers and other materials below.

FOR HEALTHCARE PROFESSIONALS ONLY

image